108 related articles for article (PubMed ID: 15012978)
1. Kringle 5 peptide-albumin conjugates with anti-migratory activity.
Léger R; Benquet C; Huang X; Quraishi O; van Wyk P; Bridon D
Bioorg Med Chem Lett; 2004 Feb; 14(4):841-5. PubMed ID: 15012978
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition by kringle 5 of human plasminogen on endothelial cell migration, an important process in angiogenesis.
Ji WR; Barrientos LG; Llinás M; Gray H; Villarreal X; DeFord ME; Castellino FJ; Kramer RA; Trail PA
Biochem Biophys Res Commun; 1998 Jun; 247(2):414-9. PubMed ID: 9642142
[TBL] [Abstract][Full Text] [Related]
3. The tumor-suppressing activity of angiostatin protein resides within kringles 1 to 3.
MacDonald NJ; Murad AC; Fogler WE; Lu Y; Sim BK
Biochem Biophys Res Commun; 1999 Oct; 264(2):469-77. PubMed ID: 10529387
[TBL] [Abstract][Full Text] [Related]
4. Lysyl 4-aminobenzoic acid derivatives as potent small molecule mimetics of plasminogen kringle 5.
Sheppard GS; Kawai M; Craig RA; Davidson DJ; Majest SM; Bell RL; Henkin J
Bioorg Med Chem Lett; 2004 Feb; 14(4):965-6. PubMed ID: 15013002
[TBL] [Abstract][Full Text] [Related]
5. Kringle 5 causes cell cycle arrest and apoptosis of endothelial cells.
Lu H; Dhanabal M; Volk R; Waterman MJ; Ramchandran R; Knebelmann B; Segal M; Sukhatme VP
Biochem Biophys Res Commun; 1999 May; 258(3):668-73. PubMed ID: 10329443
[TBL] [Abstract][Full Text] [Related]
6. Integrin alphavbeta3 is not significantly implicated in the anti-migratory effect of anti-angiogenic urokinase kringle domain.
O E; Kim HK; Hong SH; Kim CK; Hong YK; Joe YA
Oncol Rep; 2008 Sep; 20(3):631-6. PubMed ID: 18695916
[TBL] [Abstract][Full Text] [Related]
7. Mutation of human plasminogen kringle 1-5 enhances anti-angiogenic action via increased interaction with integrin alpha(v)beta(3).
Chang PC; Chang YJ; Wu HL; Chang CW; Lin CI; Wang WC; Shi GY
Thromb Haemost; 2008 Apr; 99(4):729-38. PubMed ID: 18392331
[TBL] [Abstract][Full Text] [Related]
8. Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis.
Ji WR; Castellino FJ; Chang Y; Deford ME; Gray H; Villarreal X; Kondri ME; Marti DN; Llinás M; Schaller J; Kramer RA; Trail PA
FASEB J; 1998 Dec; 12(15):1731-8. PubMed ID: 9837863
[TBL] [Abstract][Full Text] [Related]
9. DGDA, a local sequence of the kringle 2 domain, is a functional motif of the tissue-type plasminogen activator's antiangiogenic kringle domain.
Kim HK; Joe YA
Biochem Biophys Res Commun; 2010 Jan; 391(1):166-9. PubMed ID: 19903452
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo antiangiogenic activity of a novel deca-peptide derived from human tissue-type plasminogen activator kringle 2.
Su L; Xu X; Zhao H; Gu Q; Zou H
Biochem Biophys Res Commun; 2010 Jun; 396(4):1012-7. PubMed ID: 20471363
[TBL] [Abstract][Full Text] [Related]
11. Characterization and biological activities of recombinant human plasminogen kringle 1-3 produced in Escherichia coli.
You WK; So SH; Sohn YD; Lee H; Park DH; Chung SI; Chung KH
Protein Expr Purif; 2004 Jul; 36(1):1-10. PubMed ID: 15177278
[TBL] [Abstract][Full Text] [Related]
12. Human glioma cell BT325 expresses a proteinase that converts human plasminogen to kringle 1-5-containing fragments.
Li F; Yang J; Liu X; He P; Ji S; Wang J; Han J; Chen N; Yao L
Biochem Biophys Res Commun; 2000 Nov; 278(3):821-5. PubMed ID: 11095991
[TBL] [Abstract][Full Text] [Related]
13. Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth.
Cao Y; Chen A; An SS; Ji RW; Davidson D; Llinás M
J Biol Chem; 1997 Sep; 272(36):22924-8. PubMed ID: 9278456
[TBL] [Abstract][Full Text] [Related]
14. Disruption of interkringle disulfide bond of plasminogen kringle 1-3 changes the lysine binding capability of kringle 2, but not its antiangiogenic activity.
Lee H; Kim HK; Lee JH; You WK; Chung SI; Chang SI; Park MH; Hong YK; Joe YA
Arch Biochem Biophys; 2000 Mar; 375(2):359-63. PubMed ID: 10700393
[TBL] [Abstract][Full Text] [Related]
15. Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells.
Cao Y; Ji RW; Davidson D; Schaller J; Marti D; Söhndel S; McCance SG; O'Reilly MS; Llinás M; Folkman J
J Biol Chem; 1996 Nov; 271(46):29461-7. PubMed ID: 8910613
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen kringle 5-engineered glioma cells block migration of tumor-associated macrophages and suppress tumor vascularization and progression.
Perri SR; Nalbantoglu J; Annabi B; Koty Z; Lejeune L; François M; Di Falco MR; Béliveau R; Galipeau J
Cancer Res; 2005 Sep; 65(18):8359-65. PubMed ID: 16166313
[TBL] [Abstract][Full Text] [Related]
17. [Expression and characterization of Kringle 1-4.5 domains of human plasminogen].
Zhou QW; Xie JL; Xin L; Xu R; Ye Q; Li ZP; Gan RB
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Feb; 35(2):138-42. PubMed ID: 12545220
[TBL] [Abstract][Full Text] [Related]
18. The X-ray crystallographic structure of the angiogenesis inhibitor angiostatin.
Abad MC; Arni RK; Grella DK; Castellino FJ; Tulinsky A; Geiger JH
J Mol Biol; 2002 May; 318(4):1009-17. PubMed ID: 12054798
[TBL] [Abstract][Full Text] [Related]
19. Soluble tissue actor interferes with angiostatin-mediated inhibition of endothelial cell proliferation by lysine-specific interaction with plasminogen kringle domains.
Albrecht S; Magdolen V; Herzog U; Miles L; Kirschenhofer A; Baretton G; Luther T
Thromb Haemost; 2002 Dec; 88(6):1054-9. PubMed ID: 12529759
[TBL] [Abstract][Full Text] [Related]
20. Generation of angiostatin-like fragments from plasminogen by prostate-specific antigen.
Heidtmann HH; Nettelbeck DM; Mingels A; Jäger R; Welker HG; Kontermann RE
Br J Cancer; 1999 Dec; 81(8):1269-73. PubMed ID: 10604721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
